Summary & Overview
HCPCS C1779: Pacemaker Lead, Transvenous VDD Single Pass
HCPCS Level II code C1779 denotes a transvenous VDD single-pass pacemaker lead, a component used in cardiac pacing systems that provides ventricular pacing with dual-chamber sensing on a single lead. Nationally, this code matters because it identifies a specific device component essential to implantable pacemaker procedures and affects device billing, device supply tracking, and claims adjudication for cardiac implant services.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines how these payers commonly handle device component coding and claims for pacemaker systems and highlights payer coverage considerations relevant to implantable lead billing.
Readers will learn the clinical context for C1779, typical sites of service for procedures involving this lead, and what is commonly reported on facility and professional claims. The piece summarizes standard coding usage, common modifiers associated with device/component reporting (listed separately), and available national policy context. Data not available in the input is noted where applicable. This summary provides a concise reference for coding professionals, hospital billing teams, and clinicians involved in pacemaker implantation and device management.
Billing Code Overview
HCPCS Level II code C1779 represents a transvenous single-pass VDD pacemaker lead designed to provide both ventricular pacing and dual-chamber sensing via a single lead. The description indicates the device is a lead, pacemaker, transvenous vdd single pass.
Service type: Cardiac implantable device component (pacemaker lead placement or replacement)
Typical site of service: Cardiac catheterization lab or operating room within an acute care hospital or ambulatory surgical center, where pacemaker systems are implanted or revised.
Clinical & Coding Specifications
Clinical Context
A 72-year-old patient with symptomatic sinus node dysfunction presents for implantation of a single-pass transvenous VDD pacemaker lead (C1779) to provide atrial sensing and ventricular pacing without a separate atrial lead. Typical workflow begins with pre-procedure evaluation in the electrophysiology clinic, including review of prior ECGs, device interrogation if applicable, medication reconciliation (anticoagulation plan), and informed consent. On the day of the procedure the patient is admitted to an ambulatory surgery center or hospital cardiac catheterization/electrophysiology laboratory. Under conscious sedation or monitored anesthesia care, vascular access is obtained (usually left subclavian or cephalic vein). A single-pass VDD lead is advanced transvenously and positioned so that the ventricular pacing electrode is in the right ventricular apex or septum while the floating atrial sensing section is positioned in the right atrium to detect atrial activity. Lead stability and sensing/pacing thresholds are confirmed intra-procedurally with fluoroscopy and device testing; hemostasis is achieved and the lead is connected to a pacemaker generator implanted in a subcutaneous pocket. Post-procedural monitoring includes telemetry, chest x-ray to confirm lead position and rule out pneumothorax, device programming, and discharge instructions. Typical site of service: hospital outpatient department or ambulatory surgical center (electrophysiology lab). Typical patient scenario includes elderly patients with symptomatic bradycardia, sinus node dysfunction, or intermittent high-grade AV block where atrial sensing with single-pass lead is clinically appropriate and a dual-lead system is not required or preferred.
Coding Specifications
| Modifier | Description | When to Use |
|---|